← Browse by Condition
Medical Condition

anhedonia

Total Trials
5
Recruiting Now
5
Trial Phases
Phase 1

ClinicalMetric tracks all active clinical trials for anhedonia sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — anhedonia Clinical Trials

How many clinical trials are currently recruiting for anhedonia?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for anhedonia, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for anhedonia?
anhedonia research spans Phase 1 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a anhedonia clinical trial?
Eligibility criteria for anhedonia trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
1
Top Sponsors
The University of Texas Health Science Center, Houston 1 trial
Medical University of Vienna 1 trial
University of Pittsburgh 1 trial
BlueSkeye AI 1 trial
Guo Wenbin 1 trial

Recruiting Clinical Trials

NCT05240352
Recruiting
Developing Brain Imaging Analysis Expertise for Personalizing Transcranial Electric Stimulation in Anhedonia Treatment of Patients With Bipolar Depression
Enrollment
45 pts
Location
United States
Sponsor
The University of Texas Health...
View Trial →
NCT07490353 Phase 1
Recruiting
Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic Effects
Enrollment
85 pts
Location
Austria
Sponsor
Medical University of Vienna
View Trial →
NCT06829953
Recruiting
Get ActivE Study for At-risk Youth
Enrollment
75 pts
Location
United States
Sponsor
University of Pittsburgh
View Trial →
NCT06364488
Recruiting
TrueBlue Clinical Study - Investigating the Use of a Mobile Phone App TrueBlue for Monitoring Depression and Anxiety
Enrollment
125 pts
Location
United Kingdom
Sponsor
BlueSkeye AI
View Trial →
NCT07813169
Recruiting
Study on iTBS Regulating the Reward Circuit Function to Improve Anhedonia in Depression
Enrollment
60 pts
Location
China
Sponsor
Guo Wenbin
View Trial →

Related Conditions

depression major depressive disorder (1) depression and suicide ideation (1) depression (1) depression postpartum (1) anxiety in pregnancy (1) anxiety (1) perinatal depression (1) major depression (1) melancholic depression (1) theta burst stimulation (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology